There is increasing evidence that a Th1 type immune response characterized by increased cytokine IFN-γ leads to better pulmonary outcomes and may be the preferred response for the successful control of acute and chronically infected CF patients24, 26, 43. This evidence concerns the gene IFNG and cystic fibrosis.